Sorrento Therapeutics (NASDAQ:SRNE) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report sent to investors on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance SRNE opened at $0.12 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 0.88 […]
More Stories
David Brainard Sells 29,248 Shares of EverQuote, Inc. (NASDAQ:EVER) Stock
EverQuote, Inc. (NASDAQ:EVER – Get Free Report) CTO David Brainard sold 29,248 shares of EverQuote stock in a transaction that...
Knowles Corporation Completes Sale of Consumer MEMS Microphone Business to SyntiantITASCA, Ill., December 30, 2024 – Knowles Corporation (NYSE: KN) (“Knowles” or the “Company”), a prominent manufacturer of specialty electronic components, announced t
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Patrick Dennis Gamble Purchases 10,000 Shares of Quipt Home Medical Corp. (CVE:QIP) Stock
Quipt Home Medical Corp. (CVE:QIP – Get Free Report) Senior Officer Patrick Dennis Gamble purchased 10,000 shares of the stock...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Director Sells $57,000.00 in Stock
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) Director Adeoye Y. Olukotun sold 2,850 shares of the company’s stock in...
ACRES Commercial Realty Corp. (NYSE:ACR) Major Shareholder Eagle Point Credit Management Sells 420 Shares
ACRES Commercial Realty Corp. (NYSE:ACR – Get Free Report) major shareholder Eagle Point Credit Management sold 420 shares of the...
CES Energy Solutions Corp. (TSE:CEU) Receives C$10.59 Average PT from Analysts
CES Energy Solutions Corp. (TSE:CEU – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the...